Register Log-in Investor Type


QuotedData’s morning briefing 9 August 2022

In QuotedData’s morning briefing 9 August 2022:

  • BioPharma Credit (BPCR) has a US$132.5m investment in a senior secured loan to Global Blood Therapeutics. Yesterday Pfizer Inc. announced a definitive agreement to acquire Global Blood Therapeutics. The loan was invested in three different tranches with each tranche subject to different prepayment economics. Assuming the prepayment occurs on 1 October 2022, the company would be expected to receive approximately $38m in paydown, prepayment and make-whole fees. [This is great news for BioPharma Credit investors – we talked through the mechanics of these deals with the manager on a recent Friday show.]

We also have results from Diverse Income Trust and Baillie Gifford US Growth, plus a deal between Independent and Monks

Leave a Reply

Your email address will not be published. Required fields are marked *

Please review our cookie, privacy & data protection and terms and conditions policies and, if you accept, please select your place of residence and whether you are a private or professional investor.

You live in…

You are a…